Video Library

Transplant recipients often experience ongoing issues from their disease and treatment. This presentation describes typical post-transplant complications and how a survivorship plan can help survivors maintain optimal health.

Bone health is an important part of long-term recovery after bone marrow transplant and CAR T-cell therapy. This presentation explains why transplant recipients are at increased risk for bone loss and fractures, how osteoporosis develops, who should be screened, and what lifestyle changes, nutritional strategies, exercise, and medications can help maintain healthy bones and reduce fracture risk as patients age.

This presentation discusses quality of life after CAR T-cell therapy, potential short-term, late, and long-term side effects, incidence and risk factors for late and long-term side effects, how to monitor yourself for side effects, when and to whom you should report symptoms, and lifestyle changes that can help prevent or manage long-term effects of CAR T-cell therapy.

This presentation provides a detailed explanation of what an autologous stem cell transplant is, who is a good candidate, the steps involved in undergoing an autologous transplant, short- and long-term side effects, and steps survivors can take to maximize their quality of life after transplant.

This presentation looks at how the foods we eat affect the gut and overall health. Dr. Damman explains why fiber, plant nutrients, healthy fats, and fermented foods are important, and discusses common nutrition questions for transplant patients, including probiotics, digestive symptoms, and how well certain foods are tolerated.

Dr. Tara Gregory reviews maintenance therapy for multiple myeloma after stem cell transplant and CAR-T-cell therapy, including treatment options, duration, side effect management, and the growing role of minimal residual disease (MRD) testing. She also discusses how CAR-T and bispecific antibodies are shaping the future of myeloma treatment.

Graft-versus-host disease (GVHD) is a side effect that can occur after an allogeneic bone marrow/stem cell transplant (a transplant using donor cells). This presentation discusses what GVHD is, how it can affect the gastrointestinal (GI) tract, risk factors for developing GI GVHD, symptoms of GI GVHD, treatment options, and strategies patients can use to minimize symptoms and improve outcomes after GI GVHD.

This presentation discusses the incidence and type of new cancers that may occur long-term after a bone marrow/stem cell transplant or CAR T-cell therapy, why they happen, how to detect symptoms, strategies to reduce the risk of new cancers, and long-term survivorship care plans.

Life after transplant or CAR T can involve more than physical recovery. This presentation explores how survivors can find meaning and purpose after experiencing cancer, transplant, CAR T, and chronic GVHD. Drs. El-Jawahri and Traeger explain that meaning-making is not something you either have or don't have—it is a skill that can be intentionally developed. Through reflection, recognizing personal strengths and values, and identifying meaningful experiences and connections, survivors can develop new ways of understanding what they have been through and build a meaningful life moving forward.

Dr. Theresa Callard-Moore discusses sexual health and intimacy following cancer treatment and transplant, emphasizing that sexual health is an important part of overall health and well-being. She explores how physical changes, fatigue, medications, body image, vaginal or genital symptoms, and the emotional impact of treatment can affect intimacy and relationships. She then provides practical strategies for communicating with partners, rebuilding intimacy gradually, addressing physical discomfort, and finding appropriate members of a healthcare team to support sexual health.

This presentation reviews the latest advances in preventing and treating acute and chronic graft-versus-host disease (GVHD). Dr. Cutler discusses how post-transplant cyclophosphamide (PTCy) has changed GVHD prevention, new treatments for chronic GVHD, and research on combination therapies and early intervention. He also answers questions about clinical trials, treatment duration, and GVHD’s relationship to relapse.

This presentation reviews common lung complications after bone marrow transplant or CAR T-cell therapy, including BOS, organizing pneumonia, bronchiectasis, and restrictive lung disease. It also covers early diagnosis, pulmonary function testing, new imaging and treatment options, and ways to help preserve lung function and quality of life.